Post-COVID Syndrome: Our Treatment Approach
TL;DR
Post-COVID syndrome affects 10-30% of infected individuals through multiple mechanisms including viral persistence, fibrin amyloid microclots impairing microcirculation, immune dysregulation, and reactivation of latent viruses. Treatment at St. George Hospital uses a multimodal approach including therapeutic apheresis, immune modulation, hyperthermia, and targeted supplementation. The syndrome closely resembles post-infectious patterns seen in chronic Lyme and post-EBV patients.
ELI5
Long COVID happens when the virus leaves behind damage that your body cannot fully repair on its own -- tiny blood clots clogging small vessels, an immune system stuck in overdrive, and sometimes old viruses reactivating. Treatment works best when it addresses all of these problems at once, not just one.
Post-COVID Syndrome: Our Treatment Approach

At a Glance

PropertyValue
ConditionPost-COVID Syndrome
Evidence LevelModerate
Causative AgentSARS-CoV-2
Treatment Approachour facility is a multimodal inpatient program, typically spanning two to three weeks
Key TakeawayPost-COVID syndrome affects an estimated 10-30% of infected individuals. Proposed mechanisms include viral persistence, fibrin amyloid microclots impairing microcirculation, latent virus reactivation, and dysautonomia; treatment targets the mechanisms found in each patient.

Post-COVID syndrome, also called long COVID or post-acute sequelae of SARS-CoV-2 (PASC), affects an estimated 10-30% of people who contract COVID-19. At the time of writing, this represents tens of millions of people worldwide who developed a new chronic illness following a viral infection. Many of them remain without effective treatment.

The condition is real. It is measurable. And for many patients, it is debilitating.

What strikes me about post-COVID, and what shapes our perspective at St. George Hospital, is how much it resembles the post-infectious syndromes our clinic has treated for decades. Fatigue, cognitive dysfunction, autonomic dysregulation, and reactivation of latent viruses make up the clinical picture we see in patients with chronic Lyme disease, after EBV, and with other chronic infections. I grew up watching these patients. COVID-19 is a new trigger for an old pattern.

The Mechanisms

Post-COVID is a syndrome with several contributing mechanisms, and their relative importance varies from patient to patient:

Therapeutic apheresis for post-COVID inflammatory marker filtration

1. Viral Persistence

SARS-CoV-2 RNA and spike protein have been detected in tissues months after acute infection, in the gut, brain, vascular endothelium, and other sites [1]. Whether this represents viable virus or residual antigen is debated. Either way, persistent viral components may keep the immune system activated.

2. Microclots and Endothelial Dysfunction

Dr. Beate Jaeger, who collaborates with our facility, has contributed important research on the role of microclots and endothelial dysfunction in post-COVID. Fibrin amyloid microclots, which resist normal fibrinolysis, trap inflammatory molecules and impair microcirculation. This mechanism is still under investigation, but it may explain many post-COVID symptoms, particularly fatigue and cognitive dysfunction. I discuss this in detail in a dedicated article.

3. Immune Dysregulation

COVID-19 can produce lasting changes in immune function:

  • Persistent T cell activation and exhaustion
  • Reduced regulatory T cell function
  • Elevated inflammatory cytokines (IL-6, TNF-alpha, IFN-gamma) months after infection
  • Autoantibody formation (antibodies against the patient’s own tissues)

4. Viral Reactivation

SARS-CoV-2 infection can reactivate latent viruses, particularly EBV, CMV, and HHV-6, that a competent immune system had held in check. In some patients, these reactivated viruses become the primary drivers of ongoing symptoms. See my reactivated viruses article.

5. Autonomic Dysfunction

Dysautonomia is common in post-COVID, particularly postural orthostatic tachycardia syndrome (POTS) and other forms of autonomic nervous system dysregulation. Patients experience heart rate variability, blood pressure instability, exercise intolerance, and temperature regulation problems. A functional medicine protocol, including subtype identification, volume expansion, mast cell stabilization, and vagal rehabilitation, is detailed in our POTS and Dysautonomia treatment guide.

6. Mitochondrial Dysfunction

The metabolic cost of acute COVID and the ongoing immune activation deplete mitochondrial function. Many post-COVID patients present with the same mitochondrial dysfunction and cellular energy profile I see in chronic fatigue syndrome and chronic infection patients.

Our Diagnostic Approach

When a post-COVID patient comes to our hospital, the evaluation covers:

  • Inflammatory markers: hsCRP, IL-6, TNF-alpha, ferritin, D-dimer
  • Coagulation assessment: fibrinogen, von Willebrand factor, microclot assessment where available
  • Immune function: lymphocyte subsets (T cells, B cells, NK cells), immunoglobulin levels, autoantibody screening
  • Viral persistence markers: SARS-CoV-2 spike protein assay, nucleocapsid antibodies
  • Reactivated virus panel: EBV (VCA IgG/IgM, EBNA, EA-D), CMV, HHV-6
  • Mitochondrial function: organic acid testing, lactate/pyruvate ratios
  • Autonomic assessment: tilt-table testing or active standing test, heart rate variability
  • Hormonal panel: COVID frequently disrupts thyroid and adrenal function
  • Micronutrient status: deficiencies are common after severe illness

Our Treatment Program

Post-COVID treatment at our facility is a multimodal inpatient program, typically spanning two to three weeks. The program is individualized based on the diagnostic findings, but common components include:

Addressing Microclots and Endothelial Dysfunction

  • Anticoagulation therapy (carefully titrated based on coagulation assessment)
  • Apheresis: therapeutic blood filtration to remove microclots, inflammatory mediators, and autoantibodies. See my apheresis article.
  • Endothelial support: targeted nutrients and medications that support vascular healing

Immune Modulation

  • IV immunoglobulin therapy in selected cases with demonstrated immune dysfunction
  • Low-dose immunotherapy approaches
  • Low-dose naltrexone (LDN) to suppress microglial overactivation and restore endorphin-mediated immune regulation (see LDN for Long COVID and Post-Viral Fatigue for our full dosing protocol)
  • Thymosin alpha-1 (TA-1) to restore T-cell competence and NK cell function in patients with confirmed immune exhaustion on lymphocyte subset testing. The mechanisms and our dosing protocol are detailed in thymosin alpha-1 for long COVID
  • Treatment of reactivated viruses when identified

Mitochondrial Rehabilitation

  • IV NAD+ therapy
  • IHHT (Intermittent Hypoxia-Hyperoxia Training) for mitochondrial biogenesis
  • Targeted mitochondrial supplementation (CoQ10, alpha-lipoic acid, B vitamins, magnesium)
  • IV nutrient therapy (high-dose vitamin C, glutathione)

Autonomic Support

  • Graduated exercise protocols designed for dysautonomic patients
  • Hydration and electrolyte optimization
  • Pharmacological support where indicated (low-dose beta-blockers, fludrocortisone, or midodrine for POTS)

Detoxification and Anti-Inflammatory Support

  • Ozone therapy (as immune modulator and antimicrobial)
  • Hepatic support
  • Anti-inflammatory supplementation

What I Have Observed

At St. George Hospital, we have treated hundreds of post-COVID patients. The outcomes vary, but the patterns are consistent:

  • Patients whose primary mechanism is microclots and endothelial dysfunction tend to respond well to apheresis and anticoagulation
  • Patients with significant viral reactivation improve when the reactivated viruses are addressed
  • Patients with predominantly mitochondrial dysfunction respond to NAD+ and IHHT protocols
  • Patients with autoimmune features often require longer treatment and may benefit from immunomodulatory therapy

The majority of patients experience meaningful improvement. Complete resolution is possible but not universal. Some patients require ongoing management. The best outcomes occur in patients who are treated comprehensively rather than piecemeal, and who address the specific mechanisms driving their individual presentation.

The Bottom Line

Post-COVID is a post-infectious syndrome with identifiable, measurable mechanisms. It is not psychosomatic and not “just anxiety”, and it can respond to targeted treatment when the underlying mechanisms are identified and addressed.

The field is evolving rapidly, and our protocols continue to be refined as new evidence emerges. In our clinical observation, a mechanism-based approach does better than waiting for spontaneous recovery, which for many patients does not come. Controlled trials comparing the two do not yet exist.

IV laser photobiomodulation in post-COVID recovery protocols

Physician-written. Written by a practicing physician at St. George Hospital. Educational content, not individual medical advice.

References

  • Swank Z, et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical Infectious Diseases. 2023;76(3):e487-e490.

This content is educational and does not constitute medical advice. Post-COVID syndrome requires individualized medical evaluation and treatment.


The Evidence Brief

Get the next deep dive in your inbox.

One evidence-graded article each week: peptides, longevity, chronic infection, immunology. Written by a practicing physician. No hype, no spam.

Email only, no medical details needed. Privacy policy.